| Randomized clinical trial of quick-release bromocriptine among patients with type 2 diabetes on overall safety and cardiovascular outcomes JM Gaziano, AH Cincotta, CM O'Connor, M Ezrokhi, D Rutty, ZJ Ma, ... Diabetes care 33 (7), 1503-1508, 2010 | 268 | 2010 |
| Origin recognition complex binding to a metazoan replication origin AK Bielinsky, H Blitzblau, EL Beall, M Ezrokhi, HS Smith, MR Botchan, ... Current Biology 11 (18), 1427-1431, 2001 | 90 | 2001 |
| A randomized, double-blind, placebo-controlled trial to assess safety and tolerability during treatment of type 2 diabetes with usual diabetes therapy and either Cycloset™ or … RE Scranton, JM Gaziano, D Rutty, M Ezrokhi, A Cincotta BMC endocrine disorders 7, 1-7, 2007 | 71 | 2007 |
| RNA-protein interactions within the internal translation initiation region of encephalomyocarditis virus RNA AV Borovjagin, MV Ezrokhi, VM Rostapshov, TY Ugarova, TF Bystrova, ... Nucleic acids research 19 (18), 4999-5005, 1991 | 66 | 1991 |
| Developmental Changes in the Sciara II/9A Initiation Zone for DNA Replication VV Lunyak, M Ezrokhi, HS Smith, SA Gerbi Molecular and cellular biology 22 (24), 8426-8437, 2002 | 65 | 2002 |
| Box H and box ACA are nucleolar localization elements of U17 small nucleolar RNA TS Lange, M Ezrokhi, F Amaldi, SA Gerbi Molecular biology of the cell 10 (11), 3877-3890, 1999 | 54 | 1999 |
| Nucleolar Localization Elements of Xenopus laevis U3 Small Nucleolar RNA TS Lange, M Ezrokhi, AV Borovjagin, R Rivera-Leon, MT North, SA Gerbi Molecular biology of the cell 9 (10), 2973-2985, 1998 | 48 | 1998 |
| Effect of bromocriptine-QR on glycemic control in subjects with uncontrolled hyperglycemia on one or two oral anti-diabetes agents AI Vinik, AH Cincotta, RE Scranton, N Bohannon, M Ezrokhi, JM Gaziano Endocrine Practice 18 (6), 931-943, 2012 | 43 | 2012 |
| Timed bromocriptine-QR therapy reduces progression of cardiovascular disease and dysglycemia in subjects with well-controlled type 2 diabetes mellitus B Chamarthi, JM Gaziano, L Blonde, A Vinik, RE Scranton, M Ezrokhi, ... Journal of Diabetes Research 2015, 2015 | 39 | 2015 |
| Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats M Ezrokhi, S Luo, Y Trubitsyna, AH Cincotta Diabetology & Metabolic Syndrome 6, 1-18, 2014 | 39 | 2014 |
| Ribosome biogenesis: role of small nucleolar RNA in maturation of eukaryotic rRNA SA Gerbi, AV Borovjagin, M Ezrokhi, TS Lange Cold Spring Harbor symposia on quantitative biology 66, 575-590, 2001 | 36 | 2001 |
| Circadian peak dopaminergic activity response at the biological clock pacemaker (suprachiasmatic nucleus) area mediates the metabolic responsiveness to a high‐fat diet S Luo, Y Zhang, M Ezrokhi, Y Li, TH Tsai, AH Cincotta Journal of Neuroendocrinology 30 (1), e12563, 2018 | 31 | 2018 |
| Randomized clinical trial assessing the efficacy and safety of bromocriptine-QR when added to ongoing thiazolidinedione therapy in patients with type 2 diabetes mellitus H Florez, R Scranton, WR Farwell, RA DeFronzo, M Ezrokhi, JM Gaziano, ... J Diabetes Metab 2 (7), 142, 2011 | 29 | 2011 |
| Impact of bromocriptine-QR therapy on cardiovascular outcomes in type 2 diabetes mellitus subjects on metformin B Chamarthi, M Ezrokhi, D Rutty, AH Cincotta Postgraduate Medicine 128 (8), 761-769, 2016 | 25 | 2016 |
| Weighted effects of bromocriptine treatment on glucose homeostasis during hyperglycemic versus euglycemic clamp conditions in insulin resistant hamsters: bromocriptine as a … M Ezrokhi, S Luo, Y Trubitsyna, AH Cincotta J Diabetes Metab 2 (007), 1-4, 2012 | 20 | 2012 |
| Experimental dopaminergic neuron lesion at the area of the biological clock pacemaker, suprachiasmatic nuclei (SCN) induces metabolic syndrome in rats S Luo, M Ezrokhi, N Cominos, TH Tsai, CR Stoelzel, Y Trubitsyna, ... Diabetology & Metabolic Syndrome 13, 1-17, 2021 | 17 | 2021 |
| Cycloset (quick-release bromocriptine mesylate), a novel centrally acting treatment for type 2 diabetes AH Cincotta, JM Gaziano, M Ezrokhi, RE Scranton Canadian Journal of Diabetes 32 (4), 323, 2008 | 17 | 2008 |
| Intrahypothalamic circuitry regulating hypothalamic fuel sensing to induce insulin sensitivity or insulin resistance S Luo, M Ezrokhi, Y Trubitsyna, AH Cincotta Diabetologia 51, S59-S59, 2008 | 16 | 2008 |
| Circadian‐timed quick‐release bromocriptine lowers elevated resting heart rate in patients with type 2 diabetes mellitus B Chamarthi, A Vinik, M Ezrokhi, AH Cincotta Endocrinology, diabetes & metabolism 3 (1), e00101, 2020 | 11 | 2020 |
| Timed dopamine agonist treatment ameliorates both vascular nitrosative/oxidative stress pathology and aortic stiffness in arteriosclerotic, hypertensive SHR rats M Ezrokhi, Y Trubitsyna, S Lou, AH Cincotta Diabetes 59, A67-A67, 2010 | 11 | 2010 |
